Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Iulian Iancu |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Pindolol augmentation in patients with treatment-resistant panic disorder: a double-blind, placebo-controlled trial / Shmuel Hirschmann en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 5 (Octubre)
[artículo]
Título : Pindolol augmentation in patients with treatment-resistant panic disorder: a double-blind, placebo-controlled trial Tipo de documento: texto impreso Autores: Shmuel Hirschmann, Autor ; Pinhas N. Dannon, Autor ; Iulian Iancu, Autor Fecha de publicación: 2023 Artículo en la página: pp. 556-559 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Ansiolíticos, Farmacoterapia, Fluvoxamina, Trastorno de pánico, Pindolol. Resumen: The objective of this study was to determine the efficacy of pindolol as an augmentor of fluoxetine in treatment-resistant panic disorder (PD). Twenty-five outpatients having PD with or without agoraphobia were included. These patients had not responded to two different trials with antidepressants and an 8-week trial of fluoxetine 20 mg/day. Link: ./index.php?lvl=notice_display&id=31171
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 556-559[artículo] Pindolol augmentation in patients with treatment-resistant panic disorder: a double-blind, placebo-controlled trial [texto impreso] / Shmuel Hirschmann, Autor ; Pinhas N. Dannon, Autor ; Iulian Iancu, Autor . - 2023 . - pp. 556-559.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 556-559
Palabras clave: Ansiolíticos, Farmacoterapia, Fluvoxamina, Trastorno de pánico, Pindolol. Resumen: The objective of this study was to determine the efficacy of pindolol as an augmentor of fluoxetine in treatment-resistant panic disorder (PD). Twenty-five outpatients having PD with or without agoraphobia were included. These patients had not responded to two different trials with antidepressants and an 8-week trial of fluoxetine 20 mg/day. Link: ./index.php?lvl=notice_display&id=31171